Your browser doesn't support javascript.
loading
Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis.
Kano, Hiroshi; Izumi, Kouji; Hiratsuka, Kaoru; Toriumi, Ren; Nakagawa, Ryunosuke; Aoyama, Shuhei; Kamijima, Taiki; Shimada, Takafumi; Naito, Renato; Kadomoto, Suguru; Iwamoto, Hiroaki; Yaegashi, Hiroshi; Kawaguchi, Shohei; Nohara, Takahiro; Shigehara, Kazuyoshi; Kadono, Yoshifumi; Saito, Yohei; Nakagawa-Goto, Kyoko; Yoshioka, Kazuaki; Nakata, Hiroki; Lin, Wen-Jye; Mizokami, Atsushi.
Affiliation
  • Kano H; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Izumi K; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Hiratsuka K; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Toriumi R; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Nakagawa R; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Aoyama S; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Kamijima T; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Shimada T; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Naito R; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Kadomoto S; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Iwamoto H; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Yaegashi H; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Kawaguchi S; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Nohara T; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Shigehara K; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Kadono Y; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Saito Y; School of Pharmaceutical Sciences, College of Medical, Pharmaceutical and Health Science, Kanazawa University, Kanazawa, Japan.
  • Nakagawa-Goto K; School of Pharmaceutical Sciences, College of Medical, Pharmaceutical and Health Science, Kanazawa University, Kanazawa, Japan.
  • Yoshioka K; Department of Vascular Physiology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Nakata H; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Lin WJ; Department of Clinical Engineering, Faculty of Health Sciences, Komatsu University, Komatsu, Japan.
  • Mizokami A; Immunology Research Center, National Health Research Institutes, Miaoli County, Taiwan.
Cancer Sci ; 114(4): 1479-1490, 2023 Apr.
Article in En | MEDLINE | ID: mdl-36479732

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Proto-Oncogene Proteins c-akt Limits: Humans / Male Language: En Journal: Cancer Sci Year: 2023 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Proto-Oncogene Proteins c-akt Limits: Humans / Male Language: En Journal: Cancer Sci Year: 2023 Document type: Article Affiliation country: Japan